Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.
Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway.
Preliminary results after upper cervical chiropractic care in patients with chronic cerebro-spinal venous insufficiency and multiple sclerosis.
The miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2.
Tetrahydrocannabinol for tremor in multiple sclerosis.
Spinal Cord Normalization in Multiple Sclerosis.
[Side-effects of the treatment with disease modifying drugs in patients with multiple sclerosis: an analysis of register data in the Yaroslavl region.]
Reports of Patients and Relatives from the CogniCIS Study about Cognition in Clinically Isolated Syndrome: What Are Our Patients Telling Us?
Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders.
Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.
Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis.
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
[Treatment of multiple sclerosis symptoms and exacerbations].
Polymorphisms of the CD24 Gene Are Associated with Risk of Multiple Sclerosis: A Meta-Analysis.
Sunlight and Vitamin D: Necessary for Public Health.
Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.
PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease.
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders.
Live-Imaging in the CNS: New Insights on Oligodendrocytes, Myelination, and their Responses to Inflammation.
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
Alterations of calcium homeostasis in cultured rat astrocytes evoked by bioactive sphingolipids.
Fast facts: multiple sclerosis.
Diagnostic accuracy of neurophysiological criteria for early diagnosis of AIDP: A prospective study.
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
[Pharmaceutical prescription for multiple sclerosis : Evaluation of pharmaceutical consumption at private health insurance.]
Pages
« first
‹ previous
…
391
392
393
394
395
396
397
398
399
…
next ›
last »